/

Other

/

Epizyme

Epizyme

Epizyme

Verified Nov 2026

Other

·

France flag

Boulogne-Billancourt, Ile-de-France

·

Since 1929

Ipsen is a biopharmaceutical company headquartered in Boulogne-Billancourt, France, founded in 1929. It employs 5,000–10,000 people and generates estimated revenue of $1–5 billion annually. The company develops and commercializes medicines in oncology, rare diseases, and neuroscience, serving medical and industrial sectors across 88 countries. It expanded its early development pipeline through an antibody drug conjugate partnership in late 2025.

Epizyme

Verified Nov 2026

AT A GLANCE

Founded

1929

Headquarters

France flag

Boulogne-Billancourt, Ile-de-France

Employees

5,000-10,000

Ownership

Epizyme at a glance

Revenue

$1-5B

Est. band

Employees

5,000-10,000

Founded

1929

Headquarters

Boulogne-Billancourt, Ile-de-France

Industries

Automotive

Electric Vehicles

Medical

Renewable Energy

Industrial Equipment

Overview

Ipsen is a biopharmaceutical company headquartered in Boulogne-Billancourt, France, founded in 1929. It employs 5,000–10,000 people and generates estimated revenue of $1–5 billion annually. The company develops and commercializes medicines in oncology, rare diseases, and neuroscience, serving medical and industrial sectors across 88 countries. It expanded its early development pipeline through an antibody drug conjugate partnership in late 2025.

At a glance

Attribute

Detail

Founded

1929

Headquarters

Boulogne-Billancourt, Ile-de-France

Employees

5,000-10,000

Revenue

$1-5B (estimated)

What Epizyme makes

The company operates four global research and development hubs and three pharmaceutical development centers, focusing on oncology treatments such as Cabometyx and Onivyde, rare disease therapies including Bylvay, and neuroscience medicines.

Latest developments

Company details

Ipsen ranks among the top 15 biopharmaceutical companies in oncology sales globally and prioritizes external innovation partnerships to strengthen its specialty care pipeline. Epizyme was founded in 1929, has an estimated 5,000-10,000 employees, and is headquartered in Boulogne-Billancourt, Ile-de-France.

Frequently asked questions

What does Epizyme do?

Ipsen is a biopharmaceutical company headquartered in Boulogne-Billancourt, France, founded in 1929. It employs 5,000–10,000 people and generates estimated revenue of $1–5 billion annually. The company develops and commercializes medicines in oncology, rare diseases, and neuroscience, serving medical and industrial sectors across 88 countries. It expanded its early development pipeline through an antibody drug conjugate partnership in late 2025.

Where is Epizyme headquartered?

Epizyme is headquartered in Boulogne-Billancourt, Ile-de-France (65 Quai Georges Gorse, Boulogne-Billancourt, Ile-de-France, 92100).

When was Epizyme founded?

Epizyme was founded in 1929.

How big is Epizyme?

Epizyme has an estimated 5,000-10,000 employees, with revenue in the $1-5B range (estimated).

Related suppliers

Explore other suppliers in the LightSource directory:

Last verified Nov 2026. Is this your company? Request a correction.

Location & contact

Boulogne-Billancourt, Ile-de-France (HQ)Headquarters · France
Boulogne-Billancourt, Ile-de-France (HQ)65 Quai Georges Gorse, Boulogne-Billancourt, Ile-de-France, 92100, FranceHeadquarters

Evaluating suppliers like these?

This profile is part of a public-data sample of the full LightSource directory. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.